# Protocol 1 — Opioid-Free General Anesthesia + PECS/Serratus Block  
### Post-Mastectomy Breast Implant Revision  
**Version 1.0 — December 2025**

---

# **Purpose**
This protocol outlines a complete **opioid-free general anesthesia (OFIA)** pathway using **PECS I + II** or **Serratus anterior plane** regional blocks for breast implant revision.  
This is the **preferred** pathway for maximizing analgesia, minimizing PONV, and improving patient comfort.

---

# **1. Indications**
- Post-mastectomy implant revision  
- Capsular contracture (Grade III–IV)  
- Suspected infection requiring washout  
- High anxiety or anticipated postoperative pain  
- High PONV risk (Apfel ≥ 3)  
- Patient preference for opioid-free anesthesia  
- Surgeon performing extensive pocket revision  

---

# **2. Contraindications**
### **Absolute**
- Local infection at block site  
- True local anesthetic allergy  
- Patient refusal  

### **Relative**
- Therapeutic anticoagulation  
- Severe respiratory compromise  
- Baseline bradycardia (caution with dexmedetomidine)  
- Significant hepatic disease (adjust lidocaine infusion)  

---

# **3. Required Equipment**
- High-frequency linear ultrasound  
- Sterile ultrasound probe cover  
- 80–100 mm block needle  
- 0.25–0.5% bupivacaine OR 0.2–0.375% ropivacaine  
- Dexamethasone (2–4 mg) for block prolongation  
- Non-invasive cardiac and neuromuscular monitoring  
- Standard GA airway equipment (LMA or ETT)  

---

# **4. Preoperative Preparation**
**Premedication:**  
- Acetaminophen 1000 mg PO  
- Celecoxib 200–400 mg PO (if no renal/GI contraindication)  
- Gabapentin 300 mg PO (optional)

**IV Access:**  
- One 20G or 18G peripheral IV

**Antibiotics:**  
- Cefazolin 2–3 g IV (or Clindamycin/Vancomycin if allergic)

**Monitoring:**  
- Standard ASA monitors  
- Consider arterial line only for severe cardiovascular disease (rare)

---

# **5. Regional Block (PECS I + PECS II or Serratus)**
### **5.1 PECS I Block**
**Targets:**  
Medial & lateral pectoral nerves → analgesia over pectoralis major/minor.

**Technique:**  
- Ultrasound identify pectoralis major/minor  
- Inject 10 mL local anesthetic between the two muscles

---

### **5.2 PECS II Block**
**Targets:**  
Intercostobrachial, 3rd–6th intercostal nerves, long thoracic nerve.

**Technique:**  
- Ultrasound identify pectoralis minor and serratus anterior  
- Inject 15–20 mL between pectoralis minor and serratus

---

### **5.3 Serratus Plane Block (Alternative)**
**Targets:**  
Thoracic intercostal nerves → lateral wall coverage.

**Technique:**  
- Inject 20–30 mL superficial or deep to serratus anterior

---

# **6. Induction (Opioid-Free)**
**Recommended sequence:**

1. **Midazolam** 1–2 mg IV (optional)  
2. **Lidocaine** 1–1.5 mg/kg IV bolus  
3. **Propofol** 1.5–2 mg/kg IV  
4. **Ketamine** 0.2–0.3 mg/kg IV   
   *Provides analgesia & reduces propofol requirement.*  
5. **Rocuronium** 0.6–1.0 mg/kg (if using ETT)  
6. Secure airway with **LMA** or **ETT**  

---

# **7. Maintenance**
### **Volatile or TIVA Options**
- **Sevoflurane** 1–2%  
**OR**  
- **Propofol infusion** 75–125 mcg/kg/min

### **Infusions**
- **Dexmedetomidine** 0.2–0.6 mcg/kg/hr (no bolus recommended)  
- **Lidocaine infusion** 1 mg/kg/hr (max 2 mg/kg/hr)

### **Ventilation Targets**
- VT 6–8 mL/kg IBW  
- RR adjusted to maintain ETCO₂ 32–38 mmHg  
- FiO₂ 30–40% unless otherwise indicated  

### **Hemodynamic Goals**
- SBP > 90 mmHg  
- HR 55–80 bpm  
- Treat hypotension with phenylephrine/ephedrine  
- Avoid high-dose beta-blockers while dexmedetomidine is running

---

# **8. Intraoperative Analgesia Strategy**
- PECS/Serratus blocks provide primary analgesia  
- Local infiltration by surgeon (bupivacaine or ropivacaine) strongly encouraged  
- No intraoperative opioids  
- Consider repeat ketamine 5–10 mg IV for stimulation moments  
- Maintain normothermia  

---

# **9. PONV Prophylaxis**
Recommended regimen:
- **Ondansetron** 4 mg IV  
- **Dexamethasone** 4–8 mg IV  
- **Scopolamine patch** (optional)  
- **Avoid nitrous oxide**

OFA + regional = **lowest PONV risk profile**.

---

# **10. Emergence**
**Steps:**
1. Discontinue dexmedetomidine 10–15 minutes before wake-up  
2. Stop lidocaine infusion  
3. Reverse NMB if ETT used  
4. Remove LMA/ETT when patient follows commands  
5. Smooth wake-up expected with minimal agitation  

**Pain goals upon emergence:**  
Target pain score **≤ 3/10**.

---

# **11. PACU Handoff Checklist**
- Type of block performed  
- Local anesthetic used and total dose  
- Infusions used (lidocaine/dexmedetomidine)  
- Airway type (ETT or LMA)  
- Hemodynamics during case  
- PONV prophylaxis given  
- Drains placed  
- Pain level on arrival  
- Any complications  

---

# **12. PACU Orders**
- Acetaminophen q6h  
- NSAID (if not contraindicated)  
- Ice pack to chest  
- Ondansetron PRN  
- Gabapentin bedtime (optional)  
- Avoid opioids unless pain > 4/10  

---

# **13. Documentation Template**
**Block performed:** PECS I ☐  PECS II ☐  Serratus ☐  
**Local anesthetic:** __________________________  
**Infusions:**  
- Lidocaine ☐ (dose: ____________)  
- Dexmedetomidine ☐ (rate: ___________)  
**Opioids given:** Yes ☐ No ☑  
**PONV prophylaxis:** _________________________  
**Airway:** LMA ☐  ETT ☐  
**Complications:** _____________________________  

---

# **End of Protocol 1**
*Educational reference only. Follow attending guidance and institutional standards.*
